Completed
Alvopem® (Pemetrexed) Safety Assessment
NCT04843007
- Conditions
- Adenoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +16 more
- Locations
-
Not specified
Clinical trial condition
Lung Neoplasms
Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.
4,227 public trials
1,019 recruiting studies
Lung Neoplasms trial results
NCT03217071
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Fundación CENIT para la Investigación en Neurociencias Buenos Aires, Argentina
- Hospital Privado de Comunidad Mar del Plata, Argentina
- Clinica Viedma S.A. Viedma, Argentina
- UZ Brussel Brussels, Belgium
NCT03293680
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- ICO-Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain
- Consorci Sanitari de Terrassa Terrassa, Barcelona, Spain
- Hospital Universitario Sta Lucia Cartagena, Murcia, Spain
- Hospital Lluís Alcanyís Xàtiva, Valencia, Spain
NCT03958045
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
- Locations
-
- Markey Cancer Center, University of Kentucky Lexington, Kentucky, United States
NCT03345485
- Conditions
- Adnexal Diseases, Breast Diseases, Breast Neoplasms, +50 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
- Stanford University Medical Center Palo Alto, California, United States
- University of Michigan Ann Arbor, Michigan, United States
- New York University New York, United States
NCT04007068
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Institut of oncology Ljubljana Ljubljana, Slovenia
Completed
Pembrolizumab and Afatinib in Patients With Non-small Cell Lung Cancer With Resistance to Erlotinib
NCT02364609
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
NCT03004183
- Conditions
- Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +14 more
- Locations
-
- Houston Methodist Cancer Center Houston, Texas, United States
NCT01265433
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +12 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States